Clinical trial

Glycine Treatment of Prodromal Symptoms

NCT00268749

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2002-07-01

PhasePHASE2

Study timeline

Study start (unknown)2002-07-01Date precision: month

Registry last updated2012-03-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Interventions

glycineDRUG · verified · RxNorm: glycine

Sponsors & collaborators

Yale Universitylead sponsor

Stanley Medical Research Institutecollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00268749 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.